HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
E Montagna Selected Research
E Montagna Research Topics
Disease
15
Breast Neoplasms (Breast Cancer)
01/2023 - 05/2005
7
Neoplasms (Cancer)
12/2021 - 05/2005
3
Neoplasm Metastasis (Metastasis)
02/2012 - 01/2009
1
Triple Negative Breast Neoplasms
12/2021
1
Residual Neoplasm
02/2015
1
Pathologic Complete Response
09/2012
1
Inflammatory Breast Neoplasms
03/2010
1
Brain Neoplasms (Brain Tumor)
01/2009
1
Disease Progression
05/2005
1
Sclerosis
03/2003
1
Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
03/2003
Drug/Important Bio-Agent (IBA)
5
Progesterone Receptors (Progesterone Receptor)
IBA
12/2021 - 10/2008
4
Phenobarbital (Luminal)
FDA Link
03/2013 - 10/2010
3
Estrogen Receptors
IBA
03/2013 - 10/2010
2
Estrogens (Estrogen)
FDA Link
09/2012 - 10/2008
2
human ERBB2 protein
IBA
02/2012 - 10/2010
2
Trastuzumab (Herceptin)
FDA Link
01/2009 - 05/2005
1
ErbB Receptors (EGF Receptor)
IBA
12/2021
1
Epidermal Growth Factor (EGF)
IBA
12/2021
1
Hormones (Hormone)
IBA
12/2021
1
Cyclin-Dependent Kinase 4
IBA
12/2021
1
Progesterone
FDA Link
Generic
09/2012
1
Lapatinib (GW572016)
FDA Link
03/2010
1
Capecitabine (Xeloda)
FDA Link
03/2010
1
Taxoids (Taxanes)
IBA
10/2008
1
taxane
IBA
05/2005
1
oxidized low density lipoprotein
IBA
03/2003
1
Cholesterol
IBA
03/2003
Therapy/Procedure
7
Drug Therapy (Chemotherapy)
01/2023 - 05/2005
7
Therapeutics
12/2021 - 05/2005
2
Neoadjuvant Therapy
02/2015 - 09/2012
1
Combined Modality Therapy
06/2008